跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
GAVISCON DOUBLE ACTION TABLETS
Approved
STANDARD
GAVISCON DOUBLE ACTION TABLETS
Unknown
🇸🇬 Health Sciences Authority
Approval Date
Jan 13, 2026
Approval ID
7fc3d9033dc8450d
Company
Unknown
Type
Standard
Approval Details
Approval Id
7fc3d9033dc8450d
Drug Name
GAVISCON DOUBLE ACTION TABLETS
Active Ingredients
SODIUM ALGINATE
250MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jan 13, 2026
Approval ID
7fc3d9033dc8450d
Type
Standard
Back to HSA Approvals
GAVISCON DOUBLE ACTION TABLETS - HSA Drug Approval Details